Moreover, our "annotated cohort" is from overwhelmingly early‐stage NSCLC patients, and we have no data on the potential clinical behavior without STING targeted specific treatments administered in advanced‐stage patients. The gene discussed is STING1; the disease is non-small cell lung carcinoma.